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Abstract
Objective To explore knowledge and beliefs of long-term smokers
about lung cancer, associated risk factors and lung cancer screening.
Design Qualitative study theoretically framed by the expanded
Health Belief Model based on four focus group discussions. Content
analysis was performed to identify themes of knowledge and beliefs
about lung cancer, associated risk factors and lung cancer screening
among long-term smokers’ who had and had not been screened for
lung cancer.
Methods Twenty-six long-term smokers were recruited; two groups
(n = 9; n = 3) had recently been screened and two groups (n = 7;
n = 7) had never been screened.
Results While most agreed lung cancer is deadly, confusion or inaccu-
rate information exists regarding the causes and associated risk factors.
Knowledge related to lung cancer screening and how it is performed
was low; awareness of long-term smoking’s association with lung
cancer risk remains suboptimal. Perceived beneﬁts of screening identi-
ﬁed include: (i) ﬁnding lung cancer early; (ii) giving peace of mind; and
(iii) motivation to quit smoking. Perceived barriers to screening identi-
ﬁed include: (i) inconvenience; (ii) distrust; and (iii) stigma.
Conclusions Perceived barriers to lung cancer screening, such as dis-
trust and stigma, must be addressed as lung cancer screening
becomes more widely implemented. Heightened levels of health-care
system distrust may impact successful implementation of screening
programmes. Perceived smoking-related stigma may lead to low
levels of patient engagement with medical care and decreased cancer
screening participation. It is also important to determine modiﬁable
targets for intervention to enhance the shared decision-making pro-
cess between health-care providers and their high-risk patients.
Lung cancer is the leading cause of cancer-
related death in the United States regardless of
gender or ethnicity.1 More than 50% of these
patients are diagnosed with advanced, incurable
disease2; individuals with Stage III and IV lung
cancer have 5-year relative survival rates of 5%
and 1%, respectively.1,3 Tobacco smoking is the
number one risk factor for lung cancer and has
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been linked to 90% of all lung cancer cases.
Long-term smokers age 55 or older who have a
minimum of a 30 pack-year tobacco smoking
history and currently smoke, or have quit within
the past 15 years, are at greatest risk for the
development of lung cancer. Pack-year is deﬁned
as number of packs of cigarettes smoked per day
multiplied by number of years smoked. Current
lung cancer screening guidelines are focused on
long-term smokers.4 The term ‘long-term smo-
ker’ is frequently deﬁned as individuals with a 30
pack-year or more tobacco smoking history in
lung cancer screening guidelines and is deﬁned
as such in this paper.4–6 This study was under-
taken to explore the knowledge and beliefs of
long-term smokers about lung cancer, associated
risk factors and lung cancer screening.
Lung cancer screening
Lung cancer screening with low-dose computed
tomography (LDCT) in long-term smokers has
been shown to decrease relative lung cancer-
related mortality by 20%.7 In response to
empiric ﬁndings, the United States Preventive
Services Task Force (USPSTF) has issued lung
cancer screening guidelines recommending
annual LDCT for long-term smokers.5 The
USPSTF’s Grade B recommendation reﬂects
their conclusion that available evidence was suf-
ﬁcient, with high certainty, that annual LDCT
will yield moderate to substantial beneﬁts for
this high-risk group. Further, in the United
States (US), the Centers for Medicare and Medi-
caid Services (CMS) approved coverage of
LDCT for its high-risk members in Febru-
ary 2015.8
As lung cancer screening becomes widely
implemented, participation is likely to be inﬂu-
enced by many factors, including individual,
provider and health-care system-related vari-
ables.3,9–12 With the recent release of screening
guidelines in the USA, eﬀorts to increase provi-
der and health-care system awareness are
underway.6,13 The American Cancer Society
published a continuing medical education pro-
gramme to educate providers on: (i) the new
guidelines; (ii) results of lung cancer screening
clinical trials; (iii) beneﬁts versus risks of LDCT;
and (iv) how to identify patients for whom lung
cancer screening is appropriate.4 Many health-
care systems have incorporated education and
training about these new guidelines and are
establishing formal lung cancer screening pro-
grammes. There are currently 341 lung cancer
screening (LCS) centres of excellence as desig-
nated by the Lung Cancer Alliance14 as well as
numerous others across the United States with-
out this designation.
Although enhancing provider awareness is
essential, it is also critical to understand factors
that inﬂuence screening participation among
people for whom screening is recommended.
Further, understanding individual health beliefs
about screening among long-term smokers will
help future eﬀorts to facilitate shared decision
making about lung cancer screening participa-
tion, which is a requirement of CMS coverage,
and essential for all screening-eligible patients
regardless of health-care coverage.8
Health belief model
The expanded Health Belief Model has been
used extensively to understand cancer preven-
tion and control behaviours, including
screening.15–19 For many cancers, researchers
have documented the inﬂuence of perceived risk
of the cancer as well as perceived beneﬁts of,
perceived barriers to, and self-eﬃcacy for
screening.16–18 As the model predicts, individu-
als will participate in cancer screening if they
believe: (i) they are at risk for a cancer (perceived
risk); (ii) screening will reduce the consequences
through early detection (perceived beneﬁts); (iii)
beneﬁts to participating in screening outweigh
the perceived barriers; and (iv) they can accom-
plish the tasks necessary to complete the
screening process (self-eﬃcacy).20, 21 For beha-
viour change to occur in long-term smokers
related to lung cancer screening, individuals
must believe they are at risk for lung cancer and
that getting screened will beneﬁt them. The pur-
pose of this study was to explore long-term
smokers’ perceptions of lung cancer, lung
cancer risk factors and lung cancer screening.
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Therefore, the research questions were: (i) What
do long-term smokers know and believe about
lung cancer and associated risk factors? and (ii)
What do long-term smokers know and believe
about lung cancer screening?
Methods
A qualitative research approach using focus
group discussions was chosen since this method
is recommended for collecting data involving
perceptions in a deﬁned area of interest in a per-
missive, non-threatening environment.22 Data
from focus group discussions can enhance
understanding a particular phenomenon.23 The
study was approved by the Institutional Review
Board at Indiana University.
Participants and recruitment procedures
Two categories of participants were recruited
from the central Indiana area: screened (n = 12)
and unscreened (n = 14) long-term smokers. We
believed it was important to include both groups
in the study to achieve heterogeneity in perspec-
tives based on a salient stratifying variable.
Twenty-six long-term smokers participated in
one of four focus group discussions. Two focus
groups (n = 9; n = 3) were comprised of long-
term smokers who had recently participated in
lung cancer screening and two focus groups
(n = 7; n = 7) were comprised of long-term
smokers who had never been screened. Inclusion
criteria mirrored the USPSTF lung cancer
screening guidelines: (i) age 55–80 years; (ii) cur-
rent or former smoker that has quit within the
past 15 years; and (iii) 30 pack-year tobacco
smoking history. Each participant in all four
focus groups received a $30 gift card and an
informational brochure on lung cancer risk
and screening at completion of the focus
group discussion.
Recruiting screened participants
To identify and recruit participants who had
undergone lung cancer screening with LDCT,
the research team member who was the medical
director of the lung screening clinic at Indiana
University Health (author DC) identiﬁed indi-
viduals who met the inclusion criteria. A letter
introducing the study signed by the principal
investigator (LCH) and the medical director
(DC), as well as a recruitment brochure, were
mailed to 41 potential participants. The intro-
ductory letter explained that the recipients
might be contacted regarding this study and
included a local telephone number to call to
leave a message if they wished to opt out. A
trained research assistant called individuals who
did not opt out 1 week after letters were mailed
to explain the study, answer questions and
invite participation. Of the 41 letters mailed,
two persons called to opt out and 17 were
successfully contacted by telephone for recruit-
ment. Consistent with focus group methodology
to assemble 6–8 participants per focus group,22
the remaining 22 potential participants were not
contacted because the number needed had been
reached. Of the 17 contacted, 14 (82.4%) agreed
to participate and 12 (70.6%) attended one
of the two focus group discussions for
screened participants.
Recruiting unscreened participants
To recruit long-term smokers who had not been
screened for lung cancer, community-based
recruitment eﬀorts were employed. Recruitment
ﬂyers were placed in high traﬃc areas (i.e. bus
stops, convenience stores and veterans’ commu-
nity halls), and one advertisement that ran for
3 days was placed in the local newspaper. Forty-
seven interested participants called the research
oﬃce to obtain additional information and were
screened for eligibility. Thirty (64%) were eligi-
ble; of those, 14 (47%) agreed to participate and
attend a focus group discussion; seven attended
the third focus group and seven attended the
fourth focus group.
Focus group discussions
After obtaining written informed consent, expe-
rienced moderators led the focus group
discussions using a semi-structured moderator’s
guide derived from a comprehensive review of
the literature (see Table 1 for a sample of the
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questions). Both moderators are doctorally
prepared behavioural scientists with experience
in health behaviour research related to cancer
screening. Discussions were digitally recorded
and subsequently transcribed verbatim by a
professional transcriptionist. The ﬁrst author
(LCH) compared the transcripts to the audio
recordings and made corrections as needed.
The transcripts were reviewed independently by
two researchers (LCH and SMR).
Qualitative data analysis
Data were analysed using a standard content
analysis process to identify themes in the tran-
scribed text.24,25 Neuendorf24 deﬁnes content
analysis as a systematic and objective analysis of
message characteristics in a narrative. Content
analysis is an appropriate technique when
researchers aim to make sense of qualitative data
and identify core consistencies and meanings.25
Two researchers with expertise in cancer screen-
ing research conducted the data analysis of the
focus group transcripts. The researchers read all
the transcripts in their entirety several times to
become familiar with the data. The researchers
independently coded the transcripts by provid-
ing labels for each relevant text unit, which was
any word, phrase, sentence, or story that
provided information to address the research
questions. The text units included information
about participants’ knowledge and beliefs about
lung cancer, associated risk factors and lung
cancer screening. A coding matrix was created
using a Microsoft Word table format to display
the relevant, identiﬁed text units. The 26 partici-
pants (12 participants who had been screened
and 14 participants who had never been screened
for lung cancer) were represented by the rows on
the matrix, and the categories exploring partici-
pants’ knowledge and beliefs about lung cancer,
associated risk factors and lung cancer screening
were represented by the columns. The text
units in the columns were then compared and
contrasted and independently grouped into sub-
categories by the two researchers (LCH and
SMR). The researchers then met to discuss
themes that emerged from individual coding and
to compare the degree of congruence between
coding and classiﬁcations. Discrepancies were
discussed until consensus was reached.
Results
Participants were a mean age of 66 years (SD
6.3) and had a mean education level of
14.7 years (SD 3.6). Most were Caucasian
(76.9%) and retired (76.9%). Almost half
(46.2%) were current smokers and the remain-
der were former smokers. In addition, 9 (34.6%)
participants reported a positive family history of
lung cancer. See Table 2 for complete sociode-
mographic characteristics by screening status.
While we conducted separate focus groups with
screened and unscreened participants expecting
to ﬁnd key diﬀerences between groups, the anal-
ysis revealed more similarities than diﬀerences.
The key diﬀerences noted were related to percep-
tions about lung cancer risk and aetiology.
Unscreened participants reported lung cancer
was mostly caused by environmental insults and
occupational exposure, whereas screened partici-
pants felt environmental exposure combined
with genetic predisposition for lung cancer was a
prevailing risk for the development of lung can-
cer. In the following section, we will discuss
ﬁndings common in all four groups.
Table 1 Sample items from the semi-structured moderator’s
guide
When I say the word lung cancer, what things come to
mind?
Who do you think gets lung cancer?
 Do you think that lung cancer has symptoms before it is
discovered? If so, what are some symptoms of lung cancer?
 How do doctors find lung cancer?
 Do you think that lung cancer can be treated? Cured?
 Do you think that lung cancer can be prevented? If so, how?
What is cancer screening?
What is lung cancer screening? How many of you have ever
heard of lung cancer screening?
 Do you think that lung cancer can be found early? How is
that done?
Why would you want to find lung cancer early?
 Have you ever heard of a lung scan? Can you describe it?
Who do you think should have this test? Why?
 Do you think you should have the test? Why? How
important do you think it is for you to have this test done?
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Long-term smokers’ knowledge and beliefs
about lung cancer and associated risk factors
Although knowledge of lung cancer risk factors
and causes varied, lung cancer was consistently
described as a disease that always leads to death.
When asked for details, participants described
lung cancer as dying a ‘horrible death’. The
thought of lung cancer stimulated images of
chemotherapy, smoking, breathing, inactivity,
mental strain and fear for participants.
When asked about the causes of lung cancer,
most participants focused primarily on environ-
mental and occupational exposures, emph-
asizing tobacco smoking less as a cause of lung
cancer. Participants described individuals at risk
as those who worked in machine shops and fac-
tories, construction, welding and jobs that
exposed them to asbestos, benzenes or diesel
fumes. Several participants cited environmental
exposure related to overseas military deploy-
ment as a factor that could increase an
individual’s risk of getting lung cancer. Tobacco
smoking was consistently identiﬁed as a risk fac-
tor only late in the discussion. Other important
perceived causes of lung cancer identiﬁed by par-
ticipants were second-hand smoke, genetics, and
having tuberculosis as a child or young adult.
When asked who gets lung cancer, participants
identiﬁed older individuals and people who
have had tuberculosis as most susceptible.
Illustrative comments related to occupational
exposure included:
My uncle was a plumber for most of his life, and
the stuﬀ they put on pipes gets on their skin. . .the
toxins, the benzenes that he was exposed to
through the chemicals in plumbing, may have
caused his early demise.
I’m a bus driver and all of our busses are inside the
garage right now, and of course we’re supposed to
have ventilation. . .but the diesel fuel. . .and all of
these other types of fuels that we have. . .you see
the smoke, you see the dust that’s accumulated,
you go. . .you breathe in stuﬀ.
Illustrative comments related to environ-
mental exposure, age, genetics and tobacco
smoke included the following: ‘There’s
environmental aspects we don’t like to talk
about, but they’re out there, even here’;
‘There’s all kinds of things that we inhale that
can be detrimental to our lungs. . .’; ‘I think
that as we get older, we become more vulner-
able to some things’; ‘I don’t know if I’m
Table 2 Sociodemographic characteristics by screening
status
Total
(n = 26)
Screened
(n = 12)
Unscreened
(n = 14)
n (%) n (%) n (%)
Gender
Female 18 (69) 7 (39) 11 (61)
Male 8 (31) 5 (63) 3 (37)
Race/Ethnicity
Caucasian 20 (77) 11 (55) 9 (45)
African American 5 (20) 0 (0) 5 (100)
Hispanic 1 (3) 1 (100) 0 (0)
Marital Status
Married 7 (27) 6 (86) 1 (14)
Divorced 4 (15) 1 (25) 3 (75)
Widowed 4 (15) 1 (25) 3 (75)
Single 11 (43) 4 (36) 7 (64)
Employment
Retired 20 (77) 8 (40) 12 (60)
Full-time 5 (19) 4 (80) 1 (20)
Part-time 1 (4) 0 (0) 1 (100)
Annual Income
<$20k 7 (27) 1 (14) 6 (86)
$20 001–40 000 8 (31) 5 (63) 3 (37)
$40 001–60 000 8 (31) 4 (50) 4 (50)
$60 001–80 000 1 (4) 0 (0) 1 (100)
More than $80 000 2 (7) 2 (100) 0 (0)
Insurance Status
Medicare 15 (58) 5 (33) 10 (67)
Medicaid 1 (4) 0 (0) 1 (100)
Private Insurance 8 (31) 7 (88) 1 (12)
No Insurance 2 (7) 0 (0) 2 (100)
Smoking Status
Current Smoker 12 (46) 3 (25) 9 (75)
Former Smoker 14 (54) 9 (64) 5 (36)
Family History of Lung Cancer
Yes 9 (35) 4 (44) 5 (56)
No 17 (65) 8 (47) 9 (53)
Total
(n = 26)
Screened
(n = 12)
Unscreened
(n = 14)
Mean (SD) Mean (SD) Mean (SD)
Age (years) 65.7 (6.3) 66.8 (7.2) 64.8 (5.6)
Education (years) 14.7 (3.6) 14.1 (4.4) 15.2 (3.0)
Pack-year History 63.6 (31.3) 59.3 (19.8) 67.2 (39.0)
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susceptible, but I wonder. And yes, I do think
there is a genetic component’; and ‘Years and
years ago I started smoking when I was very
young. I was only 14 and back in those days,
we didn’t have the knowledge of how bad
cigarette smoke was on you’.
During discussions about perceived causes of
lung cancer, participants conveyed distrust of
the tobacco industry, noting they believed the
industry was primarily concerned with prof-
itability and ‘in bed with the government’.
Illustrative comments of distrust of both the
government and tobacco industry include: ‘Big
business, by not smoking, by quitting smoking.
Every pack that you don’t spend. . .every time
you don’t do that, you’re keeping money out of
big business’s pocket’ and
. . .but they sell it. They tax it. They push it. Why is
it that they don’t start there, that it kills so many
people? Every time there’s a defect with General
Motors or something, there’s a recall, and some
about people dying, they’re having accidents.
Well, how come they don’t have recalls? [Female
interjects, ‘They should recall cigarettes’.] Recall
cigarettes, and alcohol, and guns, you know, and
they can’t do that. They can’t get that right
because there’s so much money, there so much
politics, and there’s so much everything else.
Overwhelmingly, participants believed lung
cancer was preventable. When asked about
ways to prevent lung cancer, participants sug-
gested not smoking and protecting one’s self
from fumes and chemicals in the work place.
In addition, a small number of participants
noted that individuals are exposed on a daily
basis to ‘seen and unseen contaminants’; one
noted, ‘it cannot be prevented unless you live
in a bowl’.
When asked about the likelihood of lung
cancer being cured, participants expressed
varying opinions. Some believed lung cancer
could be cured by surgery, with statements
such as ‘I’d say probably 80/20. Maybe 20%,
80% you’re not cured’. Others indicated radia-
tion and chemotherapy could cure lung cancer.
Still others said there were so many types of
lung cancer that they doubted cure was
an option.
Long-term smokers’ knowledge and beliefs
about lung cancer screening
The following section will present ﬁndings from
the discussion on lung cancer screening aware-
ness, including who should be screened and
perceived beneﬁts of and barriers to screening.
Awareness of lung cancer screening
When asked about lung cancer screening, most
participants were unaware that screening guide-
lines existed, and some reported not being aware
of how screening is performed. Those who were
aware expressed confusion about how it was per-
formed. One participant stated, ‘You get the
chest X-ray ﬁrst, then you get the CAT scan,
then, what’s next?” Surprisingly, there also was
some degree of confusion on how lung cancer
screening was performed even among partici-
pants who had been screened for lung cancer.
Although all in the screened group had had an
LDCT, some of these participants reported that
chest radiography was another method to screen
for lung cancer.
Who should get screened for lung cancer
When asked who should get screened for lung
cancer, most agreed that both current and for-
mer smokers should be screened. However,
many participants described their perceptions
that lung cancer screening is a ‘money-making
scam. . .like a bait and switch’. To provide con-
text, many of those who had been screened
had participated in screening in response to
LDCTs being oﬀered by many local health-
care systems (i.e. $49–$99). These participants
referred to the low cost LDCT as a means to
‘get you in the door’, and then additional test-
ing would be required if something abnormal
was found. An illustrative comment follows
and is reﬂective of a patient experience in a
US health-care system:
I hate to be kind of skeptical of modern tech-
nology. . .all of a sudden now we’re hearing
about lung screening. All of these years, how
long have cigarettes been around, and how
many people have died from lung cancer or
whatever, now we have the screen. So they built
the machine. . .it seems to me that some of these
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things that keeps coming up is almost like a
scam. It’s almost like a sales pitch. . .like telling
you, come on, get this lung screening done and
stuﬀ like that, and just like everybody else here,
the ﬁrst time you go there, oh, we seen a spot,
it was four millimeters, this and that, or what-
ever. . .come back in three months, come back
in six months, bring your insurance card with
you. Tell them to stop selling it.
Perceived beneﬁts of lung cancer screening
Three perceived beneﬁts of lung cancer screening
were identiﬁed: (i) ﬁnding lung cancer early; (ii)
giving peace of mind; and (iii) providing motiva-
tion to quit smoking. When asked about
potential beneﬁts of lung cancer screening, par-
ticipants discussed ﬁnding lung cancer early as a
beneﬁt, noting that screening is likely associated
with better survival rates. Comments such as
‘the earlier you catch it, the better possibility of
a cure’ illustrate this perceived beneﬁt of lung
cancer screening. Some participants also pointed
out that knowing what is ahead is beneﬁcial.
Participants discussed lung cancer screening as
giving peace of mind if the results are negative,
with comments such as ‘[knowing] everything is
okay’ and receiving a ‘clean bill of health’.
Finally, participants described being motivated
to quit smoking as a potential unexpected bene-
ﬁt of lung cancer screening, noting it could serve
as ‘a reminder that I need to work on
my quitting’.
Perceived barriers to lung cancer screening
Three perceived barriers to lung cancer screening
in general were described: (i) inconvenience; (ii)
perceived smoking-related stigma; and (iii) dis-
trust of the health-care system. When asked
about potential barriers to lung cancer screen-
ing, participants described inconvenience as
a barrier, particularly time constraints and
scheduling conﬂicts. Participants consistently
described perceived smoking-related stigma as a
potential barrier to lung cancer screening. Many
participants described feeling smoking-related
stigma from younger health-care providers,
describing them as ‘people that don’t know the
culture we grew up in’. Most participants dis-
cussed stigma from the perspective of being
blamed for having smoked, being made to feel
like a social outcast and ‘making me feel like
an idiot or stupid for smoking’. Finally, as
described previously, participants reported dis-
trust of government and the tobacco industry,
and they reported uncertainty about the value of
lung cancer screening, comparing ‘new machines
to screen’ to a ‘scam’.
Discussion
Several common themes were discovered among
long-term smokers regarding their perceptions
about lung cancer, its associated risk factors and
lung cancer screening. Although most individu-
als agreed that lung cancer is deadly, either
confusion or inaccurate information existed as
to the causes and associated risk factors. Partici-
pants seemed to assign greater importance to
occupational and environmental exposure and
placed less emphasis on smoking - the number
one risk factor for lung cancer that they all
shared. These ﬁndings support and extend the
work Faller et al. and Salander both ﬁnding that
some smokers externalize the cause of lung can-
cer to the presence of toxins in the working
environment or air pollution.26, 27 In addition,
our study supports the ﬁndings of Weinstein in
which some smokers attributed the cause of lung
cancer to genetic pre-disposition.28 Although
acknowledging that occupational and environ-
mental exposures and the potential synergistic
eﬀect of smoking with occupational and envi-
ronmental factors are important, for many there
seemed to be a disconnect or denial between risk
factors for lung cancer and ways to prevent lung
cancer. Although many participants identiﬁed
tobacco smoking as a risk factor only late in the
focus group discussion, these same participants
quickly identiﬁed abstinence from smoking as a
primary way to prevent lung cancer. This sug-
gests that these current and former smokers
were either not completely aware of or in denial
of the critical role tobacco plays in lung cancer
risk and aetiology. Increasing the awareness
among long-term smokers about the established
links among lung cancer, tobacco and other aeti-
ologies is important in order for long-term
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smokers to accurately assess their risk for
lung cancer.
Although participants reported that ﬁnding
lung cancer early, giving peace of mind and
being motivated to quit smoking were beneﬁts of
lung cancer screening, several important barriers
to screening also were identiﬁed. One in particu-
lar, smoking-related stigma, may serve as a
barrier to lung cancer screening. Such stigma
and its associated feelings of shame and self-
blame have been shown to inﬂuence timing of
medical help-seeking behaviour, and they are
signiﬁcantly associated with poorer quality of
life, more depressive symptoms and lower levels
of patient engagement in medical care.29,30 In
turn, less engagement in medical care is likely to
be associated with decreased cancer screen-
ing participation.
Another important potential screening bar-
rier among long-term smokers may be related
to distrust of the tobacco industry and govern-
ment. Participants seemed to agree that the
tobacco industry and government mutually
worked for each other’s interests and expressed
a tremendous amount of scepticism and dis-
trust about both systems which may be
associated with health-care system distrust.
Heightened levels of distrust may impact the
successful implementation of lung cancer
screening programmes nationwide by serving
as an impediment to screening behaviour.
Careful attention to how lung cancer screening
is marketed should include a focus on the
shared decision-making component in order to
address issues of distrust. A helpful approach
might be to involve screening-eligible patients
in the development of advertising materials
and highlighting that lung cancer screening is
the only screening modality to date in the US
that requires a shared decision-making visit for
reimbursement.8 The shared decision-making
process is essential in helping an individual
weigh the beneﬁts and harms of screening in
order to make an informed and mutually
agreeable decision to screen or not screen.
Responsible approaches to both the implemen-
tation and marketing of lung cancer screening
can reinforce the importance of screening
rather than unintentional perception that it is
something to be feared.
It is also important to note that there were
unscreened focus group participants who were
either unaware or had misconceptions about lung
cancer screening. Secondary to the new recom-
mendation and expected, many did not know
that lung cancer screening was available. How-
ever, several participants had misconceptions
about how screening is performed. Screening is a
concept that is commonly misconstrued; diagnos-
tic testing in response to symptoms is frequently
perceived as screening. As lung cancer screening
is implemented, increased eﬀorts to educate those
at risk for lung cancer about the purpose of
screening as a means of identifying potentially
cancerous pulmonary nodules early will be key to
success. In addition, because lung cancer screen-
ing involves a range of beneﬁts and potential
risks, it is essential that all screening-eligible
patients for whom lung cancer screening is
recommended receive patient education and
counselling. Further, integration of a shared deci-
sion-making process is imperative and should
include patient preference elicitation and values
clariﬁcation prior to the patient’s decision. Inte-
gration of this important process in lung cancer
screening recommendations will help address the
need to improve overall communication and
decision making about screening.
Limitations
As with all studies, results should be interpreted
in the context of limitations. The greatest
limitation in this study was lack of geographic
sample diversity. Although the focus groups of
unscreened participants were composed of indi-
viduals recruited from the community, the group
of 12 screened participants was recruited from
one health-care system in one Midwestern city.
Therefore, the results are potentially biased by
the nuances of the local health-care system. In
addition, because 35% (n = 9) of the partici-
pants indicated a family history of lung cancer,
this may have impacted their perceptions of lung
cancer from personal experience. Future studies
exploring lung cancer screening beliefs in
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screened individuals should include participants
from multiple, geographically diverse health-
care systems to provide a more robust picture.
However, one of the strengths of this study was
demographic diversity. We had a diverse repre-
sentation of ethnicity, ages and current and
former smokers. However, the groups were not
homogeneous in smoking status since each
group included both current and former smok-
ers, which may have inﬂuenced the dynamics of
the discussions. Future studies should consider
homogeneity of smoking status in constructing
focus groups.
In addition, a speciﬁc focus on the risks of
screening was not included and would likely
have been helpful in the process of understand-
ing perspectives on lung cancer screening.
Future research should include an exploration
of perceived risks and harms of screening.
Finally, although every eﬀort was made to
encourage openness in the focus group discus-
sions, the social pressure created by a focus
group setting may have yielded diﬀerent results
than individual interviews. However, four sepa-
rate focus groups were held and the themes that
emerged were consistent across the diﬀer-
ent groups.
Conclusion
Screening has the potential to identify lung
cancer in long-term smokers at an earlier stage,
resulting in increased survival rates. Lung can-
cer screening is a new recommendation in the
United States for long-term smokers who meet
age and pack-year smoking parameters, but
there are multilevel variables (i.e. individual,
provider and health-care system level) that will
aﬀect the successful implementation of such
screening programmes. By understanding long-
term smokers’ perceptions of lung cancer, its
associated risk factors and lung cancer screen-
ing, we can address gaps in understanding for
high risk, long-term smokers in order to
enhance the shared decision-making process
about this new screening modality. Most
importantly, the scepticism that exists among
lung cancer screening-eligible patients makes a
patient-centred approach to lung cancer screen-
ing more critical. Health-care providers must
recognize and address both the beneﬁts and
potential risks of lung cancer screening and col-
laborate with their screening-eligible patients
towards a mutually agreeable shared decision
that is right for both the individual’s situation
and preferences.
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